BG103985A - Multicyclic derivatives of erythromycin - Google Patents

Multicyclic derivatives of erythromycin

Info

Publication number
BG103985A
BG103985A BG103985A BG10398599A BG103985A BG 103985 A BG103985 A BG 103985A BG 103985 A BG103985 A BG 103985A BG 10398599 A BG10398599 A BG 10398599A BG 103985 A BG103985 A BG 103985A
Authority
BG
Bulgaria
Prior art keywords
multicyclic
erythromycin
compound
derivatives
pharmaceutically acceptable
Prior art date
Application number
BG103985A
Other languages
Bulgarian (bg)
English (en)
Inventor
Yat Sun Or
George Griesgraber
Daniel Chu
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG103985A publication Critical patent/BG103985A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG103985A 1997-05-29 1999-12-10 Multicyclic derivatives of erythromycin BG103985A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86545397A 1997-05-29 1997-05-29
PCT/US1998/010501 WO1998054197A1 (en) 1997-05-29 1998-05-22 Multicyclic erythromycin derivatives

Publications (1)

Publication Number Publication Date
BG103985A true BG103985A (en) 2000-07-31

Family

ID=25345545

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103985A BG103985A (en) 1997-05-29 1999-12-10 Multicyclic derivatives of erythromycin

Country Status (26)

Country Link
EP (1) EP0984975B1 (hu)
JP (1) JP4368950B2 (hu)
KR (1) KR20010013041A (hu)
CN (1) CN1258299A (hu)
AR (1) AR013081A1 (hu)
AT (1) ATE238330T1 (hu)
AU (1) AU7591298A (hu)
BG (1) BG103985A (hu)
BR (1) BR9809489A (hu)
CA (1) CA2290421C (hu)
CO (1) CO4950620A1 (hu)
DE (1) DE69813798T2 (hu)
DK (1) DK0984975T3 (hu)
ES (1) ES2197472T3 (hu)
HU (1) HUP0004809A3 (hu)
IL (1) IL132482A0 (hu)
MX (1) MXPA99011001A (hu)
NO (1) NO995842L (hu)
NZ (1) NZ500531A (hu)
PL (1) PL337066A1 (hu)
PT (1) PT984975E (hu)
SI (1) SI0984975T1 (hu)
SK (1) SK160299A3 (hu)
TR (1) TR199902820T2 (hu)
WO (1) WO1998054197A1 (hu)
ZA (1) ZA984488B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE250076T1 (de) * 1999-06-07 2003-10-15 Abbott Lab 6-o-carbamat ketolide derivate
US20100035832A1 (en) * 2005-01-12 2010-02-11 Alpharma Aps Macrolides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE145212T1 (de) * 1992-04-22 1996-11-15 Taisho Pharmaceutical Co Ltd 5-0-desosaminylerythronolide a derivate
ES2218604T3 (es) * 1995-11-08 2004-11-16 Abbott Laboratories Derivados triciclicos de eritromicina.

Also Published As

Publication number Publication date
ES2197472T3 (es) 2004-01-01
JP4368950B2 (ja) 2009-11-18
DK0984975T3 (da) 2003-08-11
PL337066A1 (en) 2000-07-31
AR013081A1 (es) 2000-12-13
WO1998054197A1 (en) 1998-12-03
JP2002500669A (ja) 2002-01-08
EP0984975A1 (en) 2000-03-15
EP0984975B1 (en) 2003-04-23
NO995842L (no) 2000-01-26
CO4950620A1 (es) 2000-09-01
NZ500531A (en) 2001-07-27
DE69813798D1 (en) 2003-05-28
DE69813798T2 (de) 2004-02-19
SK160299A3 (en) 2000-06-12
HUP0004809A3 (en) 2001-11-28
ATE238330T1 (de) 2003-05-15
CN1258299A (zh) 2000-06-28
TR199902820T2 (xx) 2000-04-21
MXPA99011001A (es) 2003-09-10
PT984975E (pt) 2003-09-30
AU7591298A (en) 1998-12-30
CA2290421A1 (en) 1998-12-03
NO995842D0 (no) 1999-11-29
IL132482A0 (en) 2001-03-19
ZA984488B (en) 1998-12-02
SI0984975T1 (en) 2004-02-29
KR20010013041A (ko) 2001-02-26
CA2290421C (en) 2007-05-08
BR9809489A (pt) 2000-06-20
HUP0004809A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
BG103969A (en) C-4"-substituted macrolide derivatives
BG103947A (en) Derivatives of 9-oxymerythromycin
TR199901127T2 (xx) Antibakteriyel etkili 6-O-ikameli ketolitler.
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
BG104434A (en) 2-halo-6-o-substituted ketolide derivatives
BG105543A (en) Novel macrolide antibiotics
BG104340A (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
DE69631609D1 (en) Tricyclische erythromycinderivate
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
NO20001169L (no) 6,9-bro erythromycinderivater
TR200001140T2 (tr) 6, 11-Köprülü eritromisin türevleri.
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
BR9708929A (pt) Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
WO1999011651A3 (en) 3-descladinose 6-o-substituded erythromycin derivatives
MY133397A (en) Novel crystalline forms of a macrolide antibiotic
BG103985A (en) Multicyclic derivatives of erythromycin
AP9801235A0 (en) Erythromycin derivatives.
AP2002002494A0 (en) Hygromycin derivatives.
HU9803043D0 (en) Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-azo-9a-homoerythromycin-a
ES8407057A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
CA2563965A1 (en) 6-0-substituted ketolides having antibacterial activity
GEP19980890B (en) Derivatives of N1-(1,2-Cis-halogeno¬-cyclopropyl) Substituted Pyridonecarbonic Acid